Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $2 | $10 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $22 | $22 | $21 | $23 |
| Enterprise Value | $24 | $24 | $22 | $32 |
| Revenue | $10 | $9 | $8 | $8 |
| % Growth | 9.9% | 7.8% | -3.7% | – |
| Gross Profit | $7 | $6 | $6 | $6 |
| % Margin | 71.1% | 70.8% | 70.9% | 71.6% |
| EBITDA | $3 | $3 | $3 | $3 |
| % Margin | 32.6% | 32.9% | 35.4% | 38.7% |
| Net Income | -$0 | -$1 | -$0 | -$1 |
| % Margin | -0.5% | -6.8% | -2.8% | -11.2% |
| EPS Diluted | -0.13 | -1.62 | -0.59 | -2.61 |
| % Growth | 92% | -174.6% | 77.4% | – |
| Operating Cash Flow | $2 | $1 | -$1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | -$1 | $1 |